Questions and answers on Casgevy, a new CRISPR-based therapy

Here are some key questions (and answers) about the approval of Casgevy, a treatment for sickle cell disease and beta thalassemia.

Related Keywords

Boston , Massachusetts , United States , United Kingdom , California , Switzerland , Berkeley , Swiss , Teonna Woolford , Samarth Kulkarni , Jennifer Doudna , Emmanuelle Charpentier , University Of California , Innovative Genomics Institute , Regulatory Agency , Sickle Cell Reproductive Health Education Directive , Vertex Pharmaceuticals , Drug Administration , European Union , Bloomberg , Even Vertex , Verve Therapeutics , Intellia Therapeutics ,